Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Trimmed Mean01:10

Trimmed Mean

3.1K
While measuring the mean of a data set, care needs to be taken when associating the mean to its central tendency. The same goes for the arithmetic mean, the geometric mean, or the harmonic mean. This is because the presence of a single outlier data value can significantly affect the mean. That is, the mean is sensitive to fluctuations in the data set.
Although certain measures of central tendency are not sensitive to outliers, there are alternative versions of the mean that get around the...
3.1K
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

361
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
361
Regression Toward the Mean01:52

Regression Toward the Mean

6.6K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K
Censoring Survival Data01:09

Censoring Survival Data

301
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
301
Sign Test for Matched Pairs01:17

Sign Test for Matched Pairs

252
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
252
Blinding01:11

Blinding

3.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developmental circuit instability in amyotrophic lateral sclerosis: from hyperexcitability to network collapse.

Brain : a journal of neurology·2026
Same author

Hierarchical Afferent Connectivity Drives Population-Wide Bursting Dynamics in a Computational Model of Human-Derived Excitatory Neuronal Networks.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

A Causal Perspective on "Appropriate Implementation of ICH E9(R1) Addendum Strategies" (Comment on Fleming et al.).

Statistics in medicine·2026
Same author

Association between early arterial pH, base excess and lactate and 24-h mortality and neurological outcomes after cardiac arrest and cardiopulmonary resuscitation: a translational study.

Resuscitation plus·2026
Same author

Scaffold-free assembly of cortical-hippocampal circuit from modular neurospheroids: a high-throughput platform to investigate network development and dynamics.

Biofabrication·2026
Same author

When <i>in vitro</i> is not enough: <i>In silico</i> strategies to investigate functional and dynamical properties of large-scale neuronal assemblies.

APL bioengineering·2025
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Nov 1, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K

Identifying treatment effects using trimmed means when data are missing not at random.

Alex Ocampo1, Heinz Schmidli2, Peter Quarg2

  • 1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Pharmaceutical Statistics
|June 25, 2021
PubMed
Summary
This summary is machine-generated.

The trimmed means approach effectively estimates clinical trial treatment effects when patient data are missing not at random (MNAR) due to discontinuation. This method is less reliable for data missing at random.

Keywords:
clinical trialsestimandsmissing datatrimmed means

More Related Videos

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K
Detecting Behavioral Deficits in Rats After Traumatic Brain Injury
07:54

Detecting Behavioral Deficits in Rats After Traumatic Brain Injury

Published on: January 30, 2018

18.4K

Related Experiment Videos

Last Updated: Nov 1, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K
Detecting Behavioral Deficits in Rats After Traumatic Brain Injury
07:54

Detecting Behavioral Deficits in Rats After Traumatic Brain Injury

Published on: January 30, 2018

18.4K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Data Analysis

Background:

  • Patient discontinuation in clinical trials can bias outcome results.
  • Missing data that cannot be explained by observed data are termed missing not at random (MNAR).

Purpose of the Study:

  • To derive conditions for the trimmed means approach to identify average population treatment effects.
  • To evaluate the trimmed means approach for handling MNAR data in clinical trials.

Main Methods:

  • The trimmed means approach sets missing values as the worst observed outcome and trims data before efficacy calculation.
  • Simulation studies were conducted to assess the method's performance.
  • The approach was compared to existing methods using chronic pain trial data.

Main Results:

  • The trimmed means approach effectively estimates treatment efficacy for MNAR data strongly associated with unfavorable outcomes.
  • The method fails when data are missing at random.
  • Combining multiple imputation with trimmed means can improve estimates when discontinuation reasons are known.

Conclusions:

  • The trimmed means approach is a valuable tool for identifying treatment effects in the presence of MNAR data.
  • Justifiable assumptions are crucial for the reliable application of this methodology.
  • An R package, trim, is available to implement the trimmed means method.